Experimental Pharmacology of Nisoldipine: Perspectives from Long-Term Studies
暂无分享,去创建一个
[1] J. Stasch,et al. Modulation by chronic nifedipine of plasma atrial natriuretic peptide, cell Na+ transport and plasma volume in rats with renal hypertension. , 1988, Journal of hypertension.
[2] J. Stasch,et al. Role of nisoldipine on blood pressure, cardiac hypertrophy, and atrial natriuretic peptides in spontaneously hypertensive rats. , 1987, Hypertension.
[3] J. Stasch,et al. The use of a monoclonal antibody to measure plasma atriopeptins in rat. , 1986, Life sciences.
[4] J. Stasch,et al. The Renal Response to Acute Hypervolemia is Caused by Atrial Natriuretic Peptides , 1986, Journal of cardiovascular pharmacology.
[5] M. Epstein,et al. Reversal by the calcium antagonist nisoldipine of norepinephrine-induced reduction of GFR: evidence for preferential antagonism of preglomerular vasoconstriction. , 1985, The Journal of pharmacology and experimental therapeutics.
[6] M. Sanguinetti,et al. Voltage‐Dependent Block of Calcium Channel Current in the Calf Cardiac Purkinje Fiber by Dihydropyridine Calcium Channel Antagonists , 1984, Circulation research.
[7] B. Garthoff,et al. Factors involved in the antihypertensive action of calcium antagonists. , 1983, Hypertension.
[8] B. Strauer,et al. Influence of Nifedipine on Ventricular Function and Myocardial Hypertrophy in Spontaneously Hypertensive Rats , 1983, Journal of cardiovascular pharmacology.
[9] A. J. Bold. Tissue fractionation studies on the relationship between an atrial natriuretic factor and specific atrial granules. , 1982 .
[10] R. Tarazi,et al. Cardiac Hypertrophy in Spontaneously Hypertensive Rats , 1974, Circulation research.
[11] A. Scriabine,et al. Review of Nisoldipine Binding Studies , 1987 .
[12] J. Stasch,et al. Renal Effects of 1,4‐Dihydropyridines in Animal Models of Hypertension and Renal Failure , 1987, Journal of cardiovascular pharmacology.
[13] G. Giebisch,et al. Renal Clearance and Micropuncture Studies of Nisoldipine Effects in Spontaneously Hypertensive Rats , 1987, Journal of cardiovascular pharmacology.
[14] E. Zawada,et al. Renal Tubular Effect of Nisoldipine, A Calcium Channel Blocker, in Rats , 1987, Journal of cardiovascular pharmacology.
[15] L. Hertle,et al. The Effect of Nisoldipine in Experimentally Induced Renal Failure , 1987 .
[16] A. Scriabine. New drugs annual : cardiovascular drugs , 1983 .
[17] D. Hannon,et al. Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue. , 1982, The American journal of cardiology.
[18] B. Garthoff,et al. Antihypertensive effect of a calcium antagonistic drug: Regression of hypertensive cardiac hypertrophy by nifedipine , 1982 .
[19] R. Towart,et al. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552). , 1980, Arzneimittel-Forschung.